menu Search
Mounjaro KwikPen

Mounjaro KwikPen Indications/Uses

tirzepatide

Manufacturer:

Eli Lilly Italia

Distributor:

Zuellig
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Type 2 diabetes mellitus: Tirzepatide (Mounjaro) is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise: as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; in addition to other medicinal products for the treatment of diabetes.
For study results with respect to combinations, effects on glycaemic control and the populations studied, see Precautions, Interactions and Pharmacology: Pharmacodynamics under Actions.
Weight management: Tirzepatide (Mounjaro) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index(BMI) of: ≥30 kg/m2 (obesity); or ≥27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).